Industry · Health Care · close of 4 Nov 2026
Labs & Life Sciences Services Stocks
6 NSE-listed labs & life sciences services companies, largest first, with each one's stage, price and valuation after the close.
6
companies
2 (33%)
in a Stage 2 uptrend
+18.6%
3-month return, weighted by size
1 · 1 · 2
in Stage 1 · 3 · 4
Filter them in the screener →All Health Care stocks →Industry rotation →
Every labs & life sciences services stock we track
| Stock | Stage | Close | Day | 3 months | From high | RS | P/E | Yield | Market cap |
|---|---|---|---|---|---|---|---|---|---|
| DIVISLABDivi's Laboratories | Stage 2, wk 24 | ₹10,037.50 | -0.3% | +19.8% | -0.3% | 91 | 91.3 | 0.30% | ₹2.66L Cr |
| SYNGENESyngene International | Stage 4, wk 15 | ₹417.50 | +2.7% | +1.8% | -37.1% | 20 | 89.0 | 0.30% | ₹16,780 Cr |
| AARTIPHARMAarti Pharmalabs | Stage 2, wk 11 | ₹926.50 | +0.7% | +34.3% | -5.0% | 77 | 32.5 | 0.38% | ₹8,401 Cr |
| DCALDishman Carbogen Amcis | Stage 4, wk 12 | ₹154.81 | +2.5% | -17.8% | -48.0% | 9 | 146.7 | — | ₹2,427 Cr |
| VIMTALABSVimta Labs | Stage 3, wk 3 | ₹497.85 | +2.5% | -22.5% | -31.4% | 36 | 27.8 | 0.40% | ₹2,225 Cr |
| BROOKSBrooks Laboratories | Stage 1, wk 1 | ₹65.49 | +1.4% | +7.7% | -41.5% | 18 | 14.4 | — | ₹193 Cr |
Labs & Life Sciences Services Stocks: quick answers
How many labs & life sciences services stocks are in an uptrend?
As of 4 Nov 2026, 2 of the 6 NSE-listed labs & life sciences services stocks we track are in Stage 2, the uptrend phase, including Divi's Laboratories (DIVISLAB) and Aarti Pharmalabs (AARTIPHARM).
What is the largest labs & life sciences services stock?
Divi's Laboratories (DIVISLAB), with a market value of ₹2.66L Cr. It closed at ₹10,037.50 on 4 Nov 2026, in Stage 2.
Which labs & life sciences services stocks are near their 52-week high?
As of 4 Nov 2026, 2 are within 5% of a 52-week high: Divi's Laboratories (DIVISLAB) and Aarti Pharmalabs (AARTIPHARM).